Limo Chen
The University of Texas MD Anderson Cancer Center(US)
Publications by Year
Research Areas
Cancer Immunotherapy and Biomarkers, RNA modifications and cancer, Ferroptosis and cancer prognosis, Lung Cancer Research Studies, Cancer-related molecular mechanisms research
Most-Cited Works
- → Metastasis is regulated via microRNA-200/ZEB1 axis control of tumour cell PD-L1 expression and intratumoral immunosuppression(2014)977 cited
- → Targeting DNA Damage Response Promotes Antitumor Immunity through STING-Mediated T-cell Activation in Small Cell Lung Cancer(2019)860 cited
- → CD38-Mediated Immunosuppression as a Mechanism of Tumor Cell Escape from PD-1/PD-L1 Blockade(2018)460 cited
- → Epithelial–Mesenchymal Transition Is Associated with a Distinct Tumor Microenvironment Including Elevation of Inflammatory Signals and Multiple Immune Checkpoints in Lung Adenocarcinoma(2016)440 cited
- → Collagen promotes anti-PD-1/PD-L1 resistance in cancer through LAIR1-dependent CD8+ T cell exhaustion(2020)428 cited
- → Chemical genetics identify eIF2α kinase heme-regulated inhibitor as an anticancer target(2011)116 cited
- → Tumor suppression by small molecule inhibitors of translation initiation(2012)104 cited
- → Th17 cells contribute to combination MEK inhibitor and anti-PD-L1 therapy resistance in KRAS/p53 mutant lung cancers(2021)65 cited
- → Twist induces epithelial-mesenchymal transition in cervical carcinogenesis by regulating the TGF-β/Smad3 signaling pathway(2015)57 cited
- → Growth and metastasis of lung adenocarcinoma is potentiated by BMP4-mediated immunosuppression(2016)53 cited